Unknown PHASE3 INTERVENTIONAL 2-arm NCT01240291

The Clinical Role of Intravenous Glutamine in Trauma Patients Receiving Enteral Nutrition (GLINT)

Effect of Intravenous GLutamine Supplementation IN Trauma Patients Receiving Enteral Nutrition Study Protocol (GLINT Study): A Prospective, Blinded, Randomized, Placebo-controlled Clinical Trial

Sponsor: Royal Brisbane and Women's Hospital

Conditions Critically Ill Multiple Trauma

Interventions Dipeptiven normal saline

Updated 5 times since 2017 Last updated: May 22, 2012 Started: Mar 31, 2011 Primary completion: Dec 31, 2012 Completion: Jun 30, 2013

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE3 clinical study on Critically Ill and Multiple Trauma, this trial is ongoing. The trial is conducted by Royal Brisbane and Women's Hospital and has accumulated 5 data snapshots since 2011. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE3
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE3

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE3
Jun 2018 — Jan 2021 [monthly]

Unknown Status PHASE3
Jan 2017 — Jun 2018 [monthly]

Unknown Status PHASE3

First recorded

Mar 2011

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Royal Brisbane and Women's Hospital

Data source: Royal Brisbane and Women's Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Brisbane, Australia